Extremely low-dose vigabatrin for West syndrome with tuberous sclerosis

被引：0

作者：

Hino-Fukuyo, Naomi ^{[1
]}

Sato, Yuko ^{[1
]}

Kakisaka, Yosuke ^{[1
]}

Endo, Wakaba ^{[1
]}

Kubota, Yuki ^{[1
]}

Kikuchi, Atsuo ^{[1
]}

Kobayashi, Tomoko ^{[1
]}

Haginoya, Kazuhiro ^{[1
,2
]}

Uematsu, Mitsugu ^{[1
]}

Numata, Yurika ^{[1
]}

Doi, Hiroshi ^{[3
]}

Mori, Masato ^{[4
]}

Osaka, Hitoshi ^{[3
,4
]}

Kure, Shigeo ^{[1
]}

机构：

[1] Tohoku Univ, Sch Med, Dept Pediat, Sendai, Miyagi, Japan

[2] Takuto Rehabil Ctr Children, Dept Pediat Neurol, Sendai, Miyagi, Japan

[3] Tohoku Univ, Sch Med, Dept Ophthalmol, Sendai, Miyagi, Japan

[4] Jichi Med Univ, Sch Med, Dept Pediat, Yamanashi, Japan

来源：

JOURNAL OF PEDIATRIC EPILEPSY | 2013年 / 2卷 / 04期

关键词：

West syndrome; infantile spasms; tuberous screlosis complex; vigabatrin;

D O I：

10.3233/PEP-14064

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Treatment of west syndrome in patients with tuberous sclerosis, the relevant effective period and doses of vigabatrin (VGB) to avoid serious side effects still needs further investigation. We report on a Japanese girl who showed good results with a very low dose of VGB. Tonic spasms appeared at 5 mo of age. Adrenocorticotropic hormone therapy resulted in incomplete seizure control. VGB at the lowest practical dose (30 mg/kg/d) showed complete control after 3 d. With reduction of the dose to 10 mg/kg/d, side effects such as hyperactivity, irritability, and sleep disturbances improved. She was seizure- free for the next 6 mo with an improved developmental quotient. Ophthalmological evaluation revealed no abnormality. The present case illustrates that low- dose VGB therapy (10 mg/kg/d) has fewer side effects and may bring prompt seizure control in west syndrome with tuberous sclerosis.

引用

页码：255 / 258

页数：4

共 50 条

[1] Vigabatrin in the treatment of epilepsy in patients with West syndrome and tuberous sclerosis
Rotta, NT
da Silva, AR
Ohlweiler, L
Riesgo, R
ARQUIVOS DE NEURO-PSIQUIATRIA, 2003, 61 (04) : 988 - 990
[2] Extremely low-dose ACTH therapy for West syndrome in Japan
Ito, M
BRAIN & DEVELOPMENT, 2001, 23 (07): : 635 - 641
[3] West syndrome in tuberous sclerosis
Badalian, LO
Medvedev, MI
Kharlamov, DA
Levin, PG
Ilyina, ES
Iskander, MB
Turilova, MM
Alikhanov, AA
ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 1995, 95 (05): : 89 - 92
[4] Low-dose lamotrigine in West syndrome
Cianchetti, C
Pruna, D
Coppola, G
Pascotto, A
EPILEPSY RESEARCH, 2002, 51 (1-2) : 199 - 200
[5] Vigabatrin for tuberous sclerosis complex
Curatolo, P
Verdecchia, M
Bombardieri, R
BRAIN & DEVELOPMENT, 2001, 23 (07): : 649 - 653
[6] West syndrome in tuberous sclerosis complex
Husain, AM
Foley, CM
Legido, A
Chandler, DA
Miles, DK
Grover, WD
PEDIATRIC NEUROLOGY, 2000, 23 (03) : 233 - 235
[7] COMPARISON OF SEIZURE OUTCOME IN PATIENTS WITH WEST SYNDROME AFTER EXTREMELY LOW-DOSE ADRENOCORTICOTROPIC HORMONE THERAPY
Matsushima, N.
Ito, S.
Ohtani, Y.
Eto, K.
Oguni, H.
Nagata, S.
EPILEPSIA, 2017, 58 : S103 - S103
[8] WEST SYNDROME AND TUBEROUS SCLEROSIS - ONE CASE
NOUGUE, J
GIRAUD, L
NICOULET, R
REVUE DE MEDECINE DE TOULOUSE, 1981, 17 (10): : 655 - 655
[9] Low-Dose Everolimus Maintenance Therapy for Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex
Luo, Cong
Ye, Wen-Rui
Zu, Xiong-Bin
Chen, Min-Feng
Qi, Lin
Li, Yang-Le
Cai, Yi
FRONTIERS IN MEDICINE, 2021, 8
[10] Efficacy and safety of low-dose everolimus treatment for renal angiomyolipoma associated with tuberous sclerosis complex
Hatano, Takashi
Endo, Katsuhisa
Tamari, Mayumi
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (01) : 163 - 168

← 1 2 3 4 5 →